Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes

Erythropoiesis-stimulating agents are generally the first line of treatment of anemia in patients with lower-risk myelodysplastic syndrome. We prospectively investigated the predictive value of somatic mutations, and biomarkers of ineffective erythropoiesis including the flow cytometry RED score, se...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sophie, Kosmider, Olivier, Maloisel, Frédéric, Drenou, Bernard, Chapuis, Nicolas, Lefebvre, Thibaud, Karim, Zoubida, Puy, Hervé, Alary, Anne Sophie, Ducamp, Sarah, Verdier, Frédérique, Bouilloux, Cécile, Rousseau, Alice, Jacob, Marie-Christine, Debliquis, Agathe, Charpentier, Agnes, Gyan, Emmanuel, Anglaret, Bruno, Leyronnas, Cecile, Corm, Selim, Slama, Borhane, Cheze, Stephane, Laribi, Kamel, Amé, Shanti, Rose, Christian, Lachenal, Florence, Toma, Andrea, Pica, Gian Matteo, Carre, Martin, Garban, Frédéric, Mariette, Clara, Cahn, Jean-Yves, Meunier, Mathieu, Herault, Olivier, Fenaux, Pierre, Wagner-Ballon, Orianne, Bardet, Valerie, Dreyfus, Francois, Fontenay, Michaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395339/
https://www.ncbi.nlm.nih.gov/pubmed/30287621
http://dx.doi.org/10.3324/haematol.2018.203158

Ejemplares similares

Ejemplares similares